SCHEMBL6694787

SCHEMBL6694787

Brc1ccc2c(ccn2Cc2ccc(-c3ccccc3N3CCNCC3)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 8/20 0.48
HTR6 P50406 4/20 0.48
HTR1A P08908 2/20 0.48
HTR2A P28223 2/20 0.48
HTR5A P47898 1/20 0.48
PPARG P37231 2/20 0.42
SOS1 Q07889 1/20 0.37
ADRB1 P08588 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
HRH4 Q9H3N8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6693288 0.88 HTR7 (0.48) HTR7HTR6HTR1AHTR2APPARG
SCHEMBL6692591 0.88 HTR7 (0.59) HTR7HTR6HTR1AHTR2AHTR5A
SCHEMBL6700145 0.76 HTR1A (0.40) HTR7HTR6HTR1AHTR2APPARG
SCHEMBL3861264 0.74 APP (0.53) HTR7HTR6HTR2AHDAC3HDAC4
SCHEMBL27976945 0.74 HTR2A (0.55) HTR7HTR6HTR2AHDAC3HDAC4
SCHEMBL6696172 0.73 HTR6 (0.49) HTR7HTR6HTR1AHDAC1HDAC2
SCHEMBL7844529 0.73 SIGMAR1 (0.52) HTR7HTR6HTR1AHTR5AADRB1
SCHEMBL6695065 0.72 HTR7 (0.45) HTR7HTR1APPARGHRH4HTR2C
SCHEMBL27976943 0.71 HTR6 (0.52) HTR6PPARGHDAC3HDAC4HDAC1
SCHEMBL6086626 0.70 HDAC8 (0.55) HTR7HTR6HTR2AHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040229874-A1 5HT7 Antagonists and inverse agonists PFIZER INC. 2004-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040229874-A1 5HT7 Antagonists and inverse agonists HTR7, HTR1A, HTR1B HTR7 1/4885HTR6 13/4885HTR1A 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.